scholarly article | Q13442814 |
P2093 | author name string | Ibrahim A Alsarra | |
P2860 | cites work | Maltodextrin-based proniosomes | Q28366138 |
In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. | Q33270298 | ||
Novel mechanisms and devices to enable successful transdermal drug delivery | Q34334041 | ||
Liposomes and niosomes as topical drug delivery systems | Q36193206 | ||
Feasibility of transdermal delivery of fluoxetine | Q41833696 | ||
The preparation and properties of niosomes--non-ionic surfactant vesicles | Q41984007 | ||
In vitro skin permeation of estradiol from various proniosome formulations | Q43543122 | ||
Sensitive LC determination of piroxicam after in vitro transdermal permeation studies | Q43715611 | ||
Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. | Q43725883 | ||
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol | Q43750669 | ||
Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model | Q44005705 | ||
Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation | Q45081027 | ||
In vitro and in vivo percutaneous absorption of topical dosage forms: case studies | Q45262471 | ||
Nebulization of liposomes. III. The effects of operating conditions and local environment | Q46082245 | ||
Proniosomes as a drug carrier for transdermal delivery of ketorolac | Q46370501 | ||
Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers | Q46527312 | ||
Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. | Q52132079 | ||
Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion. | Q52210511 | ||
Non-ionic surfactant based vesicles (niosomes) in drug delivery | Q57610510 | ||
P433 | issue | 3 | |
P304 | page(s) | 272-278 | |
P577 | publication date | 2008-10-20 | |
P1433 | published in | Journal of Microencapsulation | Q15708887 |
P1476 | title | Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery | |
P478 | volume | 26 |
Q53819702 | Assessment of simvastatin niosomes for pediatric transdermal drug delivery. |
Q85246487 | Entrapment and release difference resulting from hydrogen bonding interactions in niosome |
Q38838736 | Fabrication and evaluation of Eudragit® polymeric films for transdermal delivery of piroxicam. |
Q46754307 | Nano-proniosomes enhancing the transdermal delivery of mefenamic acid |
Q93018045 | Niosomal Nanocarriers for Enhanced Skin Delivery of Quercetin with Functions of Anti-Tyrosinase and Antioxidant |
Q53054958 | Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo. |
Q38705821 | Technology overview and drug delivery application of proniosome |